SARS-CoV-2: a vaccine candidate effective against all variants
ANSES has taken part in preclinical trials of a potential vaccine against sarbecoviruses, the coronaviruses responsible for severe acute respiratory syndrome. In hamsters, this vaccine was equally effective against all the SARS-CoV-2 variants studied. These results suggest the potential for vaccines whose protection does not diminish with the appearance of new SARS-CoV-2 variants or new sarbecoviruses.
Beware of burns to children from disinfectants used in schools
Around a hundred accidents were caused by products used to disinfect toilets or furniture in nursery schools over the period 2017-2022. These accidents were mainly due to improper use of disinfectants. Although most of the accidents were not serious, one child required a skin graft..
MATRIX: working together to improve surveillance of foodborne pathogens in the EU
A multitude of players are involved in the surveillance of pathogenic bacteria that can be transmitted through food, from farm to fork. The European MATRIX project, which has just come to an end, sought to improve collaboration between the various bodies involved in the surveillance systems set up in each European country.
Lyme disease: an innovative vaccine candidate to make ticks less dangerous
Ticks are the leading vector of disease for animals, and rank second for humans. Lyme disease, the best-known tick-borne illness, is caused by a bacterium. Tests have been conducted on an innovative vaccine targeting the tick microbiota, with a view to reducing tick infection by this bacterium. This work was carried out by INRAE in collaboration with ANSES and the Alfort National Veterinary School, and the results were published in the journal Microbiome on 24 July.
ANSES's new 2023-2027 goals and performance contract
The new goals and performance contract (COP) between ANSES and its five supervisory ministries sets out its strategic objectives for the coming five years. Building on the previous COP, its orientations consolidate the Agency's core missions and reflect the changes it plans to undertake to address new challenges, in a national and global context marked by health crises and transformations in society and the environment – climate change and biodiversity loss in particular.
Bed bugs are a financial burden and reduce quality of life for many people in France
Between 2017 and 2022, more than one in 10 French households were infested by bed bugs. Contrary to popular belief, their presence does not indicate a lack of cleanliness, and anyone can fall victim to an infestation in their home. Moreover, bed bugs are a costly nuisance for households in metropolitan France, considering the expense of treatment and the psychological impact. The Agency therefore recommends that certain households be provided with financial assistance to cover the costs associated with exterminating bed bugs. It also recommends that professionals and private individuals favour alternative control methods instead of chemical insecticides.
Ministère de la Santé et de la Prévention 14 avenue Duquesne 75007 Paris
ANSES holds the final meeting of the One Health European Joint Programme (OHEJP). The meeting will be an opportunity to look back on the work conducted during the five years of the OHEJP. It will be held at the French Ministry of Health and Prevention on the 11th (afternoon) and 12th (morning) of September and will be broadcast live.
A method for assessing the carcinogenicity of work processes
In addition to exposure to chemical substances and products, some occupational activities and working conditions can cause or promote the onset of cancer. ANSES has developed a methodology to assess the carcinogenicity of these work processes, in order to better prevent the associated risks to workers.